ATArthur Tarricone

Arthur Tarricone

*This is an algorithmically generated author record based on publicly available information.

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arthur Tarricone has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of Tibial Transverse Transport Angiogenesis Versus Vascular Surgery in Patients with Chronic Limb Threatening Ischemia: A Systematic Review and Meta-Analysis.

    by Lawrence A Lavery, Arthur Tarricone, Chengyu Xie, Lee C Rogers, Michael C Siah, Allen Gee, Prakash Krishnan, Dane Wukich, David C Lavery, Joseph Alderete

    Peripheral arterial disease (PAD) is one of the most common underlying causes of major lower extremity amputations (LEAs). Often revascularization is not adequate to save the leg. Tibial Transverse Transport (TTT) represents a revolutionary approach to increase angiogenesis in people with critical limb threatening ischemia (CLTI). A systematic review and meta-analysis was conducted across six databases. Inclusion criteria required studies to evaluate TTT combined with revascularization versus revascularization or TTT alone as a monotherapy. Outcomes analyzed included tarsal-metatarsal amputation (TMA), wound healing, and change in visual analogue scale (VAS) for pain. A total of five studies were identified across four databases that met inclusion criteria. TTT + Revascularization was shown to have a protective effect in reducing follow up TMA, O.R = 0.44 [0.23, 0.81], p = 0.009. TTT + Revascularization was also found to have an association with wound healing, OR = 3.25 [1.84,5.73], p = 0.0001. Four studies observed the change in Visual Analogue Scale (VAS), and the cumulative effect showed no association between either TTT + Revascularization or monotherapy with change in VAS pain pre and post procedure, standard mean difference = -0.05 [-0.16, 0.05], p = 0.33. TTT in combination with peripheral endovascular revascularization offers a promising addition for patients with CLTI with lower incidence of TMA increase rates of wound healing. However, considering the limited studies available and overall small sample size, further trials are necessary to understand the relationship between this novel therapy and CLTI management.

  • Open Access

    Durability of the DETOUR System for Long and Complex Femoral-Popliteal Lesions: 3-Year Results From the DETOUR2 Trial

    by Sean P. Lyden, Peter A. Schneider, Ami Sood, Erik Zendejas, Peter A. Soukas, Arthur Tarricone, Prakash Krishnan

  • Open Access

    Outcomes of Self-Administered Outpatient Parenteral Antibiotic Therapy in Patients with Osteomyelitis of the Foot

    by Arthur Tarricone, Allen Gee, Nitish Thirugnanasambandam, Dane K. Wukich, Prakash Krishnan, Lawrence A. Lavery

    The objective of this paper is to compare outcomes for patients treated with healthcare administered Outpatient Parenteral Antimicrobial Therapy (H-OPAT) versus S-OPAT (self-administered antibiotics) for the treatment of foot osteomyelitis. This was a retrospective cohort study of 202 subjects with osteomyelitis that were admitted to the hospital for moderate or severe foot infections and followed for 1 year. There were 134 subjects in the H-OPAT group and 68 in the S-OPAT group. Diabetes was prevalent in 157/202 (77.7%) subjects in the study cohort. The primary outcomes were reinfection, wound healing, time until wounds healed, amputation (minor and major), mortality, rehospitalization of the same foot, and length of stay. Reinfection was defined as infection of the same site from index procedure. S-OPAT patients were more likely to require rehospitalization (O.R = 2.10 [1.11, 3.70]) and less likely to have complete wound healing within 90 days (O.R = 0.49 [0.25, 0.96]). When Kaplan Meier survival analysis was evaluated, S-OPAT patients had longer times to heal (H-OPAT; 136.0 ± 105.2 days vs S-OPAT; 183.7 ± 118.9 days, p = 0.01. There were no differences between S-OPAT and H-OPAT for 1-year wound healing, amputation, rate of reinfection, mortality, or length of stay. Overall, S-OPAT subjects demonstrated an increased association with binary wound healing at 90 days, hospitalization, and require longer antibiotic duration.

  • Open Access

    Does Antibiotic Treatment Before Bone Biopsy Affects the Identification of Bacterial Pathogens From Bone Culture in Diabetic Foot Osteomyelitis? A Systematic Review and Meta Analysis

    by Lawrence A. Lavery, Arthur N. Tarricone, Andrew William Ernest Madsen, Nitish Thirugnanasambandam, Allen Gee, Dane K. Wukich, Edgar J. G. Peters

    Our aim was to evaluate the effect of pre‐biopsy antibiotics and bacterial pathogen recovery after bone biopsy in patients suspected of having diabetic foot osteomyelitis. A meta‐analysis following PRISMA guidelines was conducted. Pubmed, EMBASE, and Cochrane Library were searched for comparative studies reporting positive culture outcomes stratified by antibiotic exposure prior to bone biopsy. Eligible studies included adult patients undergoing bone biopsy with extractable data on pre‐biopsy antibiotic use and culture positivity. Pooled odds ratios were calculated using a random‐effects model with the Mantel–Haenszel method. Statistical heterogeneity was assessed using the I 2 statistic and Cochran's Q test. Four studies met inclusion criteria. The cumulative findings showed an odds ratio of 0.78, CI [0.31, 1.98], p = 0.60, suggesting no significant difference in bacterial culture yield between groups that had antibiotic exposure and patients naïve to antibiotics before biopsy. Heterogeneity: τ 2 (REML b ) = 0.42; χ 2 = 6.11, p = 0.11; I 2 = 50%. Withholding antibiotics before bone biopsy in DFO patients does not appear to affect bacterial culture yield.


  • Open Access

    Minimally Invasive Floating Metatarsal Osteotomy for Diabetic Foot Ulcers: A Systematic Review and Meta‐Analysis

    by Arthur Tarricone, Collin E. Pehde, Lee C. Rogers, Allen Gee, Karla De La Mata, Kimberly Barron, Ian Barron, Alexandria A. Armstrong, Robert Frykberg, Nitish Tirugnanasambandam, et al.

    Minimally invasive floating metatarsal osteotomy has been proposed as a surgical strategy to address recurrent or persistent diabetic foot ulcers (DFUs) by correcting underlying biomechanical deformities. We conducted a systematic review and meta‐analysis in accordance with PRISMA guidelines, querying four databases through September 2025 for studies involving adult patients with neuropathic DFUs treated with minimally invasive floating metatarsal osteotomy and followed for at least 12 months. Six studies comprising 184 subjects (176 with DFUs, 8 prophylactic) met inclusion criteria. Pooled outcomes demonstrated a healing rate of 98% (95% CI: 0.94–1.00) with a mean time to closure of 31.7 days (95% CI: 24.1–39.3). Ulcer recurrence occurred in 4% (95% CI: 0.02–0.09), while transfer lesions developed in 14% (95% CI: 0.08–0.20) and nonunion was observed in 14% (95% CI: 0.06–0.29). The overall infection rate was 7% (95% CI: 0.04–0.12). These findings indicate that minimally invasive floating metatarsal osteotomy is a safe and effective surgical option for off‐loading neuropathic DFUs; demonstrating high healing rates, rapid time to closure and low recurrence when compared with conservative care. Larger randomised controlled trials are warranted to validate these results and establish standardised surgical indications.


  • Open Access

    Tibial Osteodistraction Angiogenesis for Diabetic Foot Ischemia: A Systematic Review and Meta‐Analysis

    by Arthur Tarricone, Allen Gee, Lee C. Rogers, David C. Lavery, Michael C. Siah, Prakash Krishnan, Dane Wukich, Luke Perry, Matthew Sideman, Lawrence A. Lavery

    Diabetes‐related lower extremity amputations (LEAs) are a significant global issue, exacerbated by the rising prevalence of diabetes and peripheral artery disease (PAD). Traditional revascularization techniques often fail in patients with severe vascular damage or comorbidities. Tibial Osteodistraction angiogenesis (ODA) represents a novel approach, leveraging angiogenesis to improve perfusion and wound healing. A systematic review was conducted across four databases. Inclusion criteria focused on studies evaluating ODA in diabetic foot ulcers and chronic ischemic wounds. Outcomes analysed included amputation rates, wound healing, mortality, and safety metrics. Eighteen studies ( n = 3000 treated with ODA) were included, with subjects aged 35–87. Diabetes prevalence was 87.8%. ODA demonstrated high limb salvage rates (92%–100%) and wound healing rates (58%–100%). Pooled analysis revealed amputation rates of 2% and mortality rates of 4%. Angiogenic cytokine levels increased post‐procedure, suggesting enhanced angiogenesis. Complications were minimal, with a 3% pin‐site infection rate and 4% major adverse limb events. ODA offers a promising addition for patients with limb‐threatening ischemia, achieving significant improvements in perfusion, wound healing, and limb salvage. Despite study heterogeneity and limitations, ODA's angiogenic benefits warrant further research through randomised clinical trials to validate its efficacy and broaden clinical adoption.

  • Open Access

    The dialysis foot‐ the impact of presenting estimated glomerular filtration rate on clinical outcomes in patients hospitalized with diabetic foot infections

    by Arthur Tarricone, Tyler L. Coye, Allen Gee, Bijan Najafi, Michael C. Siah, Lawrence A. Lavery

    To evaluate the association between presenting estimated glomerular filtration rate (eGFR) and clinical outcomes in patients hospitalized with diabetic foot infections. This retrospective cohort study included 344 patients with moderate to severe diabetic foot infections. Patients were categorized into three groups based on presenting estimated eGFR: eGFR ≥60 (eGFR >60 mL/min), eGFR 30–60 (eGFR 30–60 mL/min) and eGFR p = 0.04). Similarly, re‐hospitalization for infection at a different site also increased with decreasing eGFR (20.5% in eGFR ≥60 vs. 28.1% in eGFR 30–60 vs. 48.4% in eGFR p < 0.01). In diabetic foot infections, presenting eGFR severity did not affect rates of wound healing, time to heal, re‐infection or amputation. However, decreasing eGFR was associated with increased mortality and re‐hospitalization for infection at a different site. In this study, presenting eGFR was not a predictive value for wound healing or time until healing, however was associated with rehospitalization and overall mortality this diabetic foot population.


  • Uncontrolled Diabetes is a Strong Predictor of Amputation in End Stage Renal Disease Patients on Hemodialysis

    by Arthur Tarricone, Allen Gee, Andrew J. Boulton, Lee Rogers, Lawrence A. Lavery


  • Healing of diabetic neuropathic foot ulcers receiving standard treatment in randomised controlled trials: A random effects meta‐analysis

    by Tyler L. Coye, Miguel Bargas Ochoa, Alejandro Zulbaran‐Rojas, Bernardo Martinez Leal, Abderrahman Ouattas, Arthur Tarricone, Jayer Chung, Bijan Najafi, Lawrence A. Lavery

    This meta‐analysis aimed to systematically assess and synthesise healing rates within a 12‐ to 24‐week treatment period among patients with diabetic foot ulcers receiving standard‐of‐care interventions in randomised controlled trials. This meta‐analysis included 32 randomised controlled trials conducted between 1996 and 2023, with sample sizes ranging from 9 to 169 patients. A random‐effects model was applied to estimate pooled healing and infection rates. Heterogeneity was quantified using the I2 statistic, and publication bias was assessed using Egger's test. The results revealed a pooled healing rate of 33.15% with a 95% confidence interval (CI) of 31.18%–35.11% and an average healing time of approximately 50.14 days (standard deviation: 31.10 days). The infection proportion was determined to be 17.4% (95% CI: 12.2%–22.5%). Subgroup analysis indicated marginally higher healing rates in the ‘Saline Gauze’ group compared to the ‘Alginate’ group, although the latter exhibited a reduced infection proportion. Sensitivity analysis affirmed the robustness of these findings whereas Egger's test suggested the presence of potential publication bias concerning the healing outcomes. The standard‐of‐care interventions for diabetic foot ulcers demonstrate limited effectiveness, with only about one‐third of patients achieving wound closure. The significant heterogeneity and publication bias observed necessitate a cautious interpretation of these results. The findings highlight the need for advanced wound care strategies and personalised treatment plans to improve outcomes in diabetic foot ulcers management. Future research should focus on conducting high‐quality, well‐reported randomised controlled trials to better understand effective treatments for DFUs.


  • Open Access

    Randomized Clinical Trial to Compare Cryopreserved and Lyopreserved Umbilical Cord Tissue to Treat Complex Diabetic Foot Wounds

    by Lawrence A. Lavery, Mehmet A. Suludere, Matthew J. Johnson, Amanda L. Killeen, Katherine M. Raspovic, Peter A. Crisologo, Arthur N. Tarricone

    To compare the incidence of infection, wound closure and time to wound closure in patients treated with cryopreserved (CPUT) and lyopreserved umbilical tissue (LPUT) in complex diabetic surgical wounds. This single-blinded 12-week randomized clinical trial compared cryopreserved and lyopreserved amniotic cord tissue to treat complex diabetic foot wounds. LPUT or CRAT was applied at baseline and again after four weeks. We enrolled subjects with UT2A-D and 3A-D wounds (depth to tendon, muscle, or bone with infection and/or PAD) and excluded subjects with ABI < 0.5 or TBI < 0.3, untreated osteomyelitis, and autoimmune diseases. We used a 3-D camera to evaluate wound area and volume. The mean baseline wound areas were 12.9 ± 10.7 cm2 for CPUT and 11.7 ± 7.0 cm2 for LPUT. The mean baseline wound volume was 7.5 ± 8.1 for CPUT and 9.2 ± 10.2 cm3 for LPUT. There was no difference between CPUT and LPUT in wound closure (36.8% vs 19.0%, P = .21) or infection (10.5% vs 4.8%, P = .60). There was no difference in mean wound area reduction between CPUT and LPUT (75.9 ± 32.3% vs 65.5 ± 38.4%, P = .41), nor in mean volume reduction (85.0 ± 30.8% vs 79.9 ± 31.9%, P = .61). In addition, there was no difference in wound closure trajectories for changes in area ( P = .75) or volume ( P = .43). Cryopreserved and lyopreserved amniotic tissue provided similar results in patients with complex diabetic foot wounds.